piperacillin has been researched along with ticarcillin in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 70 (35.90) | 18.7374 |
| 1990's | 33 (16.92) | 18.2507 |
| 2000's | 63 (32.31) | 29.6817 |
| 2010's | 28 (14.36) | 24.3611 |
| 2020's | 1 (0.51) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Nordmann, P; Poirel, L; Soares, A; Soussy, CJ | 1 |
| Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J | 1 |
| Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O | 1 |
| Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
| Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Ariza, J; Dominguez, MA; Gudiol, F; Guzmán, A; Peña, C; Pujol, M; Suarez, C; Tubau, F | 1 |
| Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
| Kwon, DH; Lu, CD | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Grosso, F; Peixe, L; Quinteira, S; Ramos, H | 1 |
| Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F | 1 |
| Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
| Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
| Bonnet, R; Neuwirth, C; Robin, F; Siebor, E | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
| Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
| Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Bonnet, R; Caniça, M; Manageiro, V; Mendonça, N | 1 |
| Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Docquier, JD; Frère, JM; Rossolini, GM; Stoczko, M | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
| Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Galleni, M; Mammeri, H; Nordmann, P | 1 |
| Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
| Nordmann, P; Plésiat, P; Poirel, L; Rodriguez-Martinez, JM | 1 |
| Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS; Whichard, JM; Zioga, A | 1 |
| Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
| Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX | 1 |
| Hall, RM; Post, V | 1 |
| Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ | 1 |
| Giakkoupi, P; Miriagou, V; Papagiannitsis, CC; Pappa, O; Polemis, M; Tzouvelekis, LS; Vatopoulos, AC; Zioga, A | 1 |
| De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
| Higgins, PG; Lehmann, M; Nordmann, P; Poirel, L; Seifert, H | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 3 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
| Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
| Fortineau, N; Nordmann, P; Poirel, L; Rodriguez-Martinez, JM | 1 |
| Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
| De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM | 1 |
| Albuquerque, L; Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Al Naiemi, N; Debets-Ossenkopp, YJ; Nordmann, P; Poirel, L; Rodríguez-Martínez, JM | 1 |
| Chang, WC; Chen, CP; Chen, TL; Cho, WL; Fung, CP; Kuo, SC; Lee, YT; Siu, LK | 1 |
| Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E | 1 |
| Bertrand, X; Dehecq, B; Hocquet, D; Mariotte, P; Plésiat, P; Talon, D | 1 |
| Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S | 1 |
| Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Benvenuti, M; Calderone, V; Docquier, JD; Mangani, S; Menciassi, N; Rossolini, GM; Stoczko, M | 1 |
| Lagrutta, E; Nordmann, P; Pham, J; Poirel, L; Taylor, P | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D | 1 |
| Kunii, O; Miyashita, T; Ono, Y | 1 |
| Bercault, N; Demasure, M; Gueveler, C; Martin, P; Poisson, D | 1 |
| Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
| Moss, RB | 1 |
| Akova, M; Livermore, DM; Yang, Y | 1 |
| Kempers, J; MacLaren, DM | 1 |
| Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
| Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA | 1 |
| Branch, RA; Sabra, R | 1 |
| Basker, M; Bolister, N; Hodges, N; Marriott, C | 1 |
| Diver, JM; Thornber, D; Wise, R | 1 |
| Appelbaum, PC; Aronoff, SC; Jacobs, MR; Yamabe, S | 1 |
| Fass, RJ; Prior, RB | 1 |
| Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD | 1 |
| Elston, RA; Fraise, A; Swann, RA | 1 |
| Chin, NX; Jules, K; Neu, HC | 1 |
| Bismuth, R; Chanal, M; Cluzel, R; Duval, J; Grosset, J; Jarlier, V; Le Van Thoi, J; Sirot, D; Soussy, CJ | 1 |
| Aronoff, SC; Jacobs, MR; Johenning, S; Yamabe, S | 1 |
| Blacklock, H; Corringham, R; Devereux, S; Guimaraes, M; Hann, I; Hoffbrand, AV; Prentice, HG; Sage, R; Stirling, L; Trikka, E | 1 |
| Darrell, JH; Miall-Allen, VM; Whitelaw, AG | 1 |
| Watanakunakorn, C | 1 |
| Belobraydic, KA; Flournoy, DJ; Qadri, SM | 1 |
| Cloud, GA; Cobbs, CG; Lyon, MD; Saag, MS; Smith, KR | 1 |
| Alivisatos, MR; Bollinger, MR; Greenberg, RN | 1 |
| de Neeling, AJ; Hoekstra, JL; Stobberingh, EE; van Boven, CP; van Klingeren, V | 1 |
| Hiraga, Y; Ikuno, Y; Inoue, E; Miki, F; Murata, A; Saito, A; Sakamoto, K; Tahara, A; Tamizawa, M; Tanizawa, S | 1 |
| Bremner, DA | 1 |
| de Neeling, AJ; Rutgers, A; Schot, CS; Stobberingh, EE | 1 |
| Atogami, S; Itoyama, T; Kamihira, S; Kohno, T; Maeda, T; Moriuchi, Y; Sasagawa, I; Tomonaga, M; Tsukasaki, K; Yamaguchi, K | 1 |
| Nightingale, CH; Quintiliani, R; Zhi, JG | 1 |
| Munro, R; Rawlinson, W; Sorrell, T | 1 |
| Jehl, F; Monteil, H | 1 |
| Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
| Gibson, G; Nachamkin, I; Samel, C; Sawyer, K; Skalina, D | 1 |
| Bartzokas, CA; Mackie, MJ; Purohit, S; Reilly, JT | 1 |
| Ashton, JJ; Brandt, JT; Copelan, EA; Fass, RJ; Moeschberger, ML | 1 |
| Barry, AL; Beskid, G; Cleeland, R; Fallat, V; Isenberg, HD; Murray, PR; Pierson, C; Squires, E; Tilton, RC | 1 |
| Cox, CE | 2 |
| Barza, M; Brown, AE; Furie, B; Furie, BC | 1 |
| Cooper, CE; Griffin, KE; Slocombe, B; White, AR | 1 |
| Henry, D; Ngui-Yen, J; Skidmore, AG; Smith, A; Smith, JA | 1 |
| Akbaraly, JP; Auzerie, J; Guibert, S; Leng, JJ | 1 |
| Donowitz, GR; Harman, C; Hess, CE; Scheld, M; Williams, ME | 1 |
| Cobbs, CG; Pierce, MA; Wofford, JD | 1 |
| Aldridge, KE; Derks, FW; Marier, RL; Martin, DH; Sanders, CV | 1 |
| Andrew, JH; Dixson, S | 1 |
| Philippon, A | 1 |
| Drusano, GL; Moody, MR; Schimpff, SC; Standiford, HC; Tatem, BA; Viollier, AF | 1 |
| Holloway, WJ | 1 |
| Link, AS | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Wilkowske, CJ; Wright, AJ | 1 |
| Goto, M; Konishi, H; Nakamoto, Y; Yamamoto, I; Yamashina, H | 1 |
| Bebear, C; Latrille, J; Quentin, C; Sageaux, JC | 1 |
| Neu, HC | 1 |
| Day, DL; McDonough, J; Shuster, CW; Yasinow, D | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Babin, S; Blessing-Moore, J; Hsu, YP; Lewiston, NJ; Moss, RB | 1 |
| Bowie, WR; Buskard, N; Chow, AW; Gribble, MJ; Grossman, L; Growe, GH; Naiman, SC; Plenderleith, LH; Sacks, SL; Smith, JA | 1 |
| Creger, RJ; Falkowski, AJ | 1 |
| Croize, J; Le Noc, P; Robert, J | 1 |
| Gentry, LO; Greenberg, SB; Jemsek, JG; Martin, RR | 1 |
| Braveny, I; Dickert, H; Machka, K | 1 |
| Hirschman, SZ; Meyers, BR; Srulevitch, E; Strougo, L | 1 |
| Kaye, D; Levison, ME; Sobel, JD | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
| Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Eley, A; Greenwood, D | 1 |
| McAllister, TA | 1 |
| Hikasa, Y; Kobayashi, N; Saito, T; Sekiya, T; Tanimura, H | 1 |
| Kaneshiro, WM; Lieberman, J | 1 |
| Douglas, GF; File, TM; Johnson, LA; Salstrom, SJ; Tan, JS | 1 |
| Pennington, JE; Schiff, JB | 1 |
| Aronoff, SC; Klinger, JD | 1 |
| Chattopadhyay, B; Curnow, SR; Hall, I | 1 |
| Alpert, SE; Marx, CM | 1 |
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| File, TM; Tan, JS | 1 |
| Duval, J; Leclercq, R | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Baughman, R; Boylen, CT; Chan, JC; Charan, NB; Cormier, YC; Erickson, A; Grossman, R; Kirmani, N; Shlaes, DM; Suh, B | 1 |
| Cantrell, HF; Jones, RN; Lankford, RB; Sutton, LD | 1 |
| Chanal, C; Cluzel, R; Henquell, C; Labia, R; Sirot, D; Sirot, J | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Duncanson, FP; Norden, CW; Talan, DA; Tan, JS; Wishnow, RM | 1 |
| Duchateau, V; Husson, M; Kinzig, M; Lambert, C; Sörgel, F; Van der Auwera, P | 1 |
| Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M | 1 |
| Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
| Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA | 1 |
| Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z | 1 |
| Blumer, JL; Bonafede, ME | 1 |
| Erwin, ME; Jones, RN; Worth, S | 1 |
| Hanaki, H; Nagayama, A; Nomura, S | 1 |
| Gagliardi, NC; Nix, DE; Schentag, JJ; Spivey, JM; Symonds, WT; Thomas, JK; Wilton, JH | 1 |
| Alonso Manzanares, MA; García García, I; García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL; Muñoz Criado, S | 1 |
| Borczyk, A; Brunins, V; Harnett, N; Johnson, W; Khakhria, R; Wan, J | 1 |
| Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
| Rokosz, A; Sawicka-Grzelak, A | 1 |
| Gardner, VM; Lister, PD; Sanders, CC | 1 |
| Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
| Miranda, E; Sader, HS; Sejas, L; Tosin, I | 1 |
| Lister, PD | 1 |
| Chen, Y; Gao, L; Hou, F; Li, J | 1 |
| Fukushima, E; Hasegawa, M; Matsuda, A; Nakamura, H; Tanaka, H | 1 |
| Trissel, LA; Zhang, Y | 1 |
| Marcille, R; Sakarcan, A; Stallworth, J | 1 |
| Chandler, LJ; Poulter, M; Reisner, B; Woods, G | 1 |
| Powell, LL; Wilson, SE | 1 |
| Bangsberg, DR; Chambers, HF; Charlebois, ED; Pang, S; Perdreau-Remington, F; Winston, LG | 1 |
| Olweny, J; Stucki, ZN; Torbert, DP; WaKabongo, M | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
| Gurkan, E; Hutton-Thomas, R; Lakticová, V; Meyer, M; Rice, LB | 1 |
| Benson, CE; Boston, RC; Dietz, JP; Sertich, PL | 1 |
| Anuradha, K; Lakshmi, V; Sailaja, VV; Satheesh, T; Umabala, P | 1 |
| Kadzielska, J; Kierzkowska, M; Rokosz, A; Sawicka-Grzelak, A; Łuczak, M | 1 |
| Docquier, JD; Gutkind, G; Radice, M; Rossolini, GM; Santella, G | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Bergeron, L; Grégoire, JP; Lemieux, P; Thibeault, R | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Berrazeg, M; Broutin, I; Fournier, D; Jeannot, K; Loeffert, S; Ntsogo Enguéné, VY; Plésiat, P | 1 |
| Economou, CJP; Lipman, J; McWhinney, B; Ordoñez, J; Richards, B; Roberts, JA; Wallis, SC | 1 |
6 review(s) available for piperacillin and ticarcillin
| Article | Year |
|---|---|
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin | 1994 |
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1996 |
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
Topics: beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Penicillanic Acid; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin | 2000 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 2013 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
23 trial(s) available for piperacillin and ticarcillin
| Article | Year |
|---|---|
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Azlocillin; Aztreonam; Ceftazidime; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Immunoglobulin G; Male; Piperacillin; Skin Tests; Ticarcillin; Tobramycin | 1991 |
A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Feces; Fever; Gram-Negative Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Netilmicin; Neutropenia; Piperacillin; Random Allocation; Respiratory System; Superinfection; Ticarcillin | 1988 |
Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections.
Topics: Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Floxacillin; Gentamicins; Humans; Infant, Newborn; Male; Penicillins; Piperacillin; Ticarcillin | 1988 |
[Comparative study of BRL28500 (clavulanic acid-ticarcillin) and piperacillin in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Respiratory Tract Infections; Ticarcillin | 1987 |
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillin Resistance; Penicillins; Piperacillin; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1986 |
Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Sepsis; Ticarcillin; Urinary Tract Infections | 1986 |
Defects in vitamin K-dependent carboxylation associated with moxalactam treatment.
Topics: 1-Carboxyglutamic Acid; Adult; Humans; Moxalactam; Piperacillin; Prothrombin; Prothrombin Time; Ticarcillin; Vitamin K | 1986 |
A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Fever; Humans; Immune Tolerance; Leukocyte Count; Neutrophils; Penicillins; Piperacillin; Ticarcillin | 1985 |
Comparative trial of ticarcillin plus clavulanic acid and piperacillin in the treatment of acute bacterial infection.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1985 |
Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Gentamicins; Humans; Metabolic Clearance Rate; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1985 |
Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Gram-Negative Bacteria; Hospitalization; Humans; Male; Penicillins; Piperacillin; Respiratory Tract Infections; Sepsis; Ticarcillin; Tobramycin | 1985 |
Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacterial Infections; Child; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Hospitalization; Humans; Middle Aged; Penicillins; Piperacillin; Ticarcillin; Urinary Tract Infections | 1985 |
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Humans; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin; Tobramycin | 1983 |
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin | 1981 |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acids; Drug Combinations; Female; Hallucinations; Humans; Male; Middle Aged; Moxalactam; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1984 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam; Ticarcillin | 1994 |
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
Topics: Bacteroides Infections; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Tazobactam; Ticarcillin | 1993 |
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin | 1997 |
Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics.
Topics: Acetylglucosaminidase; Adolescent; Adult; Anti-Bacterial Agents; CD13 Antigens; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kidney Tubules; Male; Middle Aged; Piperacillin; Ticarcillin | 1997 |
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections | 1998 |
166 other study(ies) available for piperacillin and ticarcillin
| Article | Year |
|---|---|
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Enterobacter cloacae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Plasmids; Quinolones; Sequence Alignment | 2007 |
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2007 |
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2007 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Endemic Diseases; Female; Gastrointestinal Tract; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Pharynx; Pseudomonas aeruginosa; Pseudomonas Infections; Rectum; Risk Factors | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Cross Infection; Humans; Plasmids; Portugal | 2007 |
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Kinetics; Klebsiella pneumoniae | 2008 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Molecular Sequence Data; Open Reading Frames; Pectobacterium carotovorum; Phenotype; Phylogeny; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.
Topics: Asparagine; Bacterial Proteins; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Secondary; Serine | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; beta-Lactamases; Burkholderia cepacia complex; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Hydrolysis; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arginine; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Citrobacter freundii; Cysteine; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Glutamine; Humans; Hydrolysis; Inhibitory Concentration 50; Isoelectric Point; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Models, Molecular; Molecular Sequence Data; Plasmids; Salmonella enterica; Sequence Analysis, DNA; Species Specificity; Substrate Specificity; Transformation, Genetic | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2009 |
AbaR5, a large multiple-antibiotic resistance region found in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Base Sequence; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Molecular Sequence Data; Multigene Family; Polymerase Chain Reaction | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary | 2009 |
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin | 2009 |
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Polymerase Chain Reaction | 2009 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Meropenem; Molecular Sequence Data; Oxacillin; Penicillins; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thienamycins | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Protein Conformation; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
Topics: beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Escherichia coli Proteins; Molecular Sequence Data | 2010 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Integrons; Middle Aged; Molecular Sequence Data; Netherlands; Pseudomonas Infections; Pseudomonas stutzeri; Sequence Homology, Amino Acid; Substrate Specificity | 2010 |
Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Promoter Regions, Genetic; Recombination, Genetic; Sequence Analysis, DNA; Species Specificity; Tazobactam | 2010 |
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed | 2010 |
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; France; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
High-resolution crystal structure of the subclass B3 metallo-beta-lactamase BJP-1: rational basis for substrate specificity and interaction with sulfonamides.
Topics: beta-Lactamases; Bradyrhizobium; Crystallography, X-Ray; Molecular Sequence Data; Protein Structure, Secondary; Substrate Specificity; Sulfonamides | 2010 |
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2010 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2017 |
[Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin | 1991 |
[Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
Topics: Cefsulodin; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1991 |
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Half-Life; Kinetics; Penicillanic Acid; Piperacillin; Tazobactam; Ticarcillin | 1990 |
Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.
Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Hydrogen-Ion Concentration; Penicillanic Acid; Piperacillin; Tazobactam; Ticarcillin | 1990 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin | 1990 |
Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.
Topics: Animals; Drug Therapy, Combination; Kidney; Kidney Diseases; Male; Penicillins; Piperacillin; Potassium; Rats; Rats, Inbred Strains; Sodium; Ticarcillin; Tobramycin | 1990 |
Reduced susceptibility of a mucoid strain of Pseudomonas aeruginosa to lysis by ticarcillin and piperacillin.
Topics: Culture Media; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1989 |
Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acid.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acids; Escherichia coli; Hydrolysis; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Tazobactam; Ticarcillin | 1989 |
In vitro activity of YTR 830.
Topics: Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Proteus vulgaris; Sulbactam; Tazobactam; Ticarcillin | 1989 |
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1989 |
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin | 1989 |
Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
Topics: Clavulanic Acids; Diffusion; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1989 |
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Topics: Animals; Azlocillin; Bacteria; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Listeria monocytogenes; Male; Mice; Neisseriaceae; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Staphylococcus aureus; Streptococcus; Ticarcillin | 1986 |
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics].
Topics: Azlocillin; Bacteria, Aerobic; Humans; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Phenotype; Piperacillin; Ticarcillin | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Topics: Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Mezlocillin; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas; Sulbactam; Ticarcillin | 1986 |
Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Topics: Azlocillin; Carbenicillin; Dose-Response Relationship, Drug; Drug Combinations; Gentamicins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
Topics: Amikacin; Carbenicillin; Cefoperazone; Gentamicins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Culture Media; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1986 |
In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1986 |
Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Azlocillin; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbenicillin; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1987 |
In vitro susceptibility of piperacillin v timentin and ticarcillin.
Topics: Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1987 |
Activity of beta-lactamase in Pseudomonas aeruginosa as studied by HPLC.
Topics: beta-Lactamases; Buffers; Carbenicillin; Ceftazidime; Chromatography, High Pressure Liquid; Microbial Sensitivity Tests; Mutation; Piperacillin; Pseudomonas aeruginosa; Reproducibility of Results; Selection, Genetic; Sonication; Ticarcillin | 1988 |
[Combined antibiotic therapy of infections in patients with acute leukemia].
Topics: Acute Disease; Adult; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Infections; Leukemia; Middle Aged; Piperacillin; Ticarcillin | 1988 |
Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice.
Topics: Agranulocytosis; Animals; Female; Mice; Mice, Inbred A; Mice, Inbred ICR; Neutropenia; Piperacillin; Pseudomonas Infections; Ticarcillin | 1988 |
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin | 1988 |
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1987 |
In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
Topics: Amdinocillin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Piperacillin; Ticarcillin | 1988 |
Platelet-mediated bleeding caused by broad-spectrum penicillins.
Topics: Adult; Bleeding Time; Blood Platelet Disorders; Cefotaxime; Hemorrhage; Humans; Mezlocillin; Penicillins; Piperacillin; Prospective Studies; Ticarcillin | 1987 |
Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin; Ticarcillin | 1987 |
Temocillin. In vitro antibacterial activity.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cefuroxime; Dose-Response Relationship, Drug; Drug Interactions; Enterobacteriaceae; In Vitro Techniques; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1985 |
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
Topics: Anti-Bacterial Agents; Aztreonam; Clavulanic Acid; Clavulanic Acids; Enoxacin; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Piperacillin; Species Specificity; Thienamycins; Ticarcillin | 1985 |
[Transplacental transfer of 5 antibiotics by in vitro human placental perfusion].
Topics: Amoxicillin; Ampicillin; Female; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Mezlocillin; Naphthyridines; Penicillins; Perfusion; Piperacillin; Placenta; Pregnancy; Ticarcillin | 1985 |
Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women.
Topics: Acute Disease; Adolescent; Adult; Aged; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Humans; Middle Aged; Penicillins; Piperacillin; Pyelonephritis; Ticarcillin | 1985 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactamases; Cefsulodin; Ceftazidime; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Monobactams; Naphthyridines; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Efficacy and safety of ticarcillin plus clavulanic acid and piperacillin in patients with lower respiratory tract infections.
Topics: Adult; Aged; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Respiratory Tract Infections; Ticarcillin | 1985 |
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
Topics: Acinetobacter; Carbenicillin; Cefsulodin; Cephalosporins; Flavobacterium; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1981 |
The penicillins.
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Carbenicillin; Drug Administration Schedule; Drug Evaluation; Drug Hypersensitivity; Drug Synergism; Humans; Penicillin G; Penicillins; Piperacillin; Probenecid; Ticarcillin | 1983 |
Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
Topics: Adult; Anti-Bacterial Agents; Carbenicillin; Chemistry, Pharmaceutical; Drug Incompatibility; Drug Interactions; Humans; Immunoenzyme Techniques; Male; Middle Aged; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1983 |
[Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Topics: Acinetobacter; Ampicillin; Carbenicillin; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Penicillins; Phenotype; Piperacillin; Ticarcillin | 1983 |
Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.
Topics: Azlocillin; Bacteria; Cefotaxime; Ceftizoxime; Drug Interactions; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1982 |
Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida.
Topics: Ampicillin; Azlocillin; Genetic Vectors; Mezlocillin; Mutation; Penicillins; Piperacillin; Plasmids; Pseudomonas; Pseudomonas aeruginosa; Ticarcillin; Transformation, Bacterial | 1984 |
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1984 |
Allergy to semisynthetic penicillins in cystic fibrosis.
Topics: Adolescent; Adult; Benzeneacetamides; Carbenicillin; Child; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Male; Penicillanic Acid; Penicillin G; Penicillins; Piperacillin; Polylysine; Pseudomonas Infections; Radioallergosorbent Test; Ticarcillin | 1984 |
Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Topics: Azlocillin; Carbenicillin; Cefamandole; Drug Interactions; Humans; Hydroxylamine; Hydroxylamines; Immunoenzyme Techniques; In Vitro Techniques; Moxalactam; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1984 |
[Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1984 |
Antimicrobial susceptibility testing of Haemophilus parainfluenzae by a kinetic killing-curve method.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cephalothin; Chloramphenicol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Gentamicins; Haemophilus; Humans; Kinetics; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1980 |
In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Topics: Ampicillin; Azlocillin; Bacteria; Bacterial Infections; Enterobacteriaceae; Humans; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1980 |
Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
Topics: Adult; Bacteria; Carbenicillin; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1980 |
Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Azlocillin; Carbenicillin; Enterobacteriaceae; Imidazolidines; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1980 |
A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefsulodin; Cephalosporins; Mezlocillin; Naphthyridines; Nephelometry and Turbidimetry; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Sulbenicillin; Ticarcillin | 1982 |
Piperacillin against clinical isolates: antimicrobial profile and clinical role.
Topics: Bacteria; Bacterial Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1982 |
[Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
Topics: Adult; Aged; Ampicillin; Bacterial Infections; Bile; Biliary Tract Diseases; Female; Gallbladder; Humans; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Penicillins; Piperacillin; Ticarcillin; Trace Elements | 1981 |
Lectin-like factor and co-factor in serum from cystic fibrosis heterozygotes.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chromatography, Gel; Cystic Fibrosis; Genetic Carrier Screening; Humans; Immunoglobulin M; Lectins; Piperacillin; Ticarcillin | 1984 |
Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Aztreonam; Guinea Pigs; Penicillins; Piperacillin; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1984 |
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Kanamycin; Penicillin Resistance; Piperacillin; Pseudomonas Infections; Ticarcillin | 1984 |
Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
Topics: Azlocillin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1983 |
Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
Topics: Carbenicillin; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Cystitis; Hematuria; Humans; Male; Penicillins; Piperacillin; Ticarcillin | 1984 |
[Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Enzyme Inhibitors; Gentamicins; Humans; In Vitro Techniques; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam; Ticarcillin | 1995 |
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin | 1994 |
Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.
Topics: Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Enterobacteriaceae; Enterococcus faecalis; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Predictive Value of Tests; Pseudomonas aeruginosa; Staphylococcus; Tazobactam; Ticarcillin | 1994 |
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
Topics: Amoxicillin; Base Sequence; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Escherichia coli; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Piperacillin; Ticarcillin | 1994 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
Topics: Adult; beta-Lactamase Inhibitors; Biological Assay; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Serum Bactericidal Test; Tazobactam; Ticarcillin | 1993 |
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors | 1996 |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical
Topics: Acetamides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Clavulanic Acids; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality Control; Roxithromycin; Ticarcillin | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin; Xanthomonas | 1997 |
Human isolates of Salmonella Typhimurium DT104 in Ontario.
Topics: Adolescent; Adult; Aged; Ampicillin Resistance; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Infant; Middle Aged; Ontario; Penicillin Resistance; Piperacillin; Salmonella Infections; Salmonella typhimurium; Streptomycin; Sulfamethoxazole; Tetracycline Resistance; Ticarcillin | 1998 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
[Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Species Specificity; Thienamycins; Ticarcillin | 1998 |
Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.
Topics: Anti-Bacterial Agents; Cephalosporinase; Clavulanic Acid; Enzyme Induction; Enzyme Inhibitors; Genes, Bacterial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin | 1999 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin | 2000 |
Acute epiglottitis: a review of 80 patients.
Topics: Acute Disease; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Epiglottitis; Female; Humans; Japan; Laryngoscopy; Length of Stay; Male; Middle Aged; Penicillins; Piperacillin; Seasons; Steroids; Ticarcillin; Tracheotomy | 2001 |
Stability of piperacillin and ticarcillin in AutoDose infusion system bags.
Topics: Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Infusions, Intravenous; Penicillins; Piperacillin; Temperature; Ticarcillin | 2001 |
Antibiotic-induced recurring interstitial nephritis.
Topics: Adolescent; Biopsy; Clavulanic Acids; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Kidney; Methylprednisolone; Nephritis, Interstitial; Penicillins; Piperacillin; Ticarcillin | 2002 |
Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
Topics: Automation; Cefepime; Cephalosporins; Electronic Data Processing; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Software; Ticarcillin | 2002 |
Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Carrier State; Clavulanic Acids; Cross Infection; Enterococcus faecium; Female; Formularies, Hospital as Topic; Gastrointestinal Tract; Humans; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Risk Factors; Ticarcillin; Time Factors; Vancomycin Resistance | 2004 |
Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
Topics: Aeromonas; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Clavulanic Acids; Lactoferrin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin | 2004 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Clindamycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Green Fluorescent Proteins; Intestine, Small; Metronidazole; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ticarcillin | 2006 |
Comparison of ticarcillin and piperacillin in Kenney's semen extender.
Topics: Animals; Anti-Bacterial Agents; Horses; Male; Microbial Sensitivity Tests; Organ Preservation Solutions; Piperacillin; Semen Preservation; Sperm Motility; Spermatozoa; Ticarcillin | 2007 |
Sensitivity pattern of gram negative bacilli to three beta-lactam/beta-lactamase inhibitor combinations using the automated API system.
Topics: Acinetobacter; Amoxicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas; Stenotrophomonas; Tazobactam; Ticarcillin | 2007 |
[Characteristic of clinical strains of gram-negative obligate anaerobes].
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acids; Drug Resistance, Bacterial; Gram-Negative Anaerobic Bacteria; Hospitals; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Poland; Retrospective Studies; Ticarcillin | 2007 |
Purification and biochemical characterization of IMP-13 metallo-beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Piperacillin; Ticarcillin | 2011 |
Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acids; Cohort Studies; Female; Humans; Infant; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Ticarcillin | 2015 |
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
Topics: Adaptation, Physiological; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Gene Expression; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Structure, Secondary; Protein Structure, Tertiary; Pseudomonas aeruginosa; Tazobactam; Ticarcillin | 2015 |
Ticarcillin and piperacillin adsorption on to polyethersulfone haemodiafilter membranes in an ex-vivo circuit.
Topics: Adsorption; Anti-Bacterial Agents; Blood Flow Velocity; Hemodiafiltration; Humans; Membranes, Artificial; Piperacillin; Polymers; Renal Replacement Therapy; Sulfones; Ticarcillin | 2020 |